News
The global power quality equipment market is expected to reach USD 41.1 billion by 2024. It is expected to grow at a 6% CAGR ...
Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.
Optimus Primal is the leader of the Maximals in the Transformers: Beast Wars universe ... Optimus will also come with three interchangeable faces, two cyber blades, wrist cannons, a metal chain ...
Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's disease candidate from its Brainshuttle programme, a technology designed to ...
GF is teaming with Thalia to simplify analog and mixed-signal design migration and IP reuse across multiple process nodes.
Enriqueta Felip, MD, PhD, the Universitat Autònoma de Barcelona, Spain, section chief at the Vall d'Hebron University Hospital, head of the Vall d' Hebron Institute of Oncology's thoracic tumors group ...
One of the biggest rides to come to Universal Studios Hollywood in well over a decade, Transformers: The Ride – 3D represents ... Every vehicle has 3 rows of 4 people, and to expedite the boarding ...
Like many in America, Todd Martens grew up with parents who devoted the bulk of their vacation time to Disney’s theme parks. He now understands them as places to make sense of the world rather ...
Gilead’s antibody-drug conjugate Trodelvy combined with Merck’s Keytruda reduced the risk of disease progression or death in a key study of an aggressive form of … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results